Navigation Links
Genstar Capital Promotes J. Ryan Clark to Principal
Date:2/11/2008

SAN FRANCISCO, Feb. 11 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services, industrial technology, business services and software services, today announced that it has promoted J. Ryan Clark to Principal. Mr. Clark joined Genstar in 2004 and serves on the Boards of several Genstar portfolio companies, including Panolam Industries International, Inc., Fort Dearborn Company, PRA International, 21st Services, and Confie Seguros, the firm's most recent investment.

"Our people are the difference in our investments and as we continue to succeed in growing our portfolio of companies we are pleased to honor and recognize the achievements of our strong team of investment professionals," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Ryan has contributed greatly to a number of our key investments since he joined the firm and has been instrumental in building out our information and insurance services practice. All of us at Genstar congratulate him and look forward to working him for many years."

Prior to joining Genstar, Ryan was an Associate at Hellman & Friedman LLC, a private equity investment firm. Previously, he worked in the Mergers, Acquisitions and Restructuring Department at Morgan Stanley in New York. Ryan earned an MBA from the Harvard Business School, and an AB in Environmental Science and Public Policy from Harvard College.

Mr. Clark will continue to develop investment opportunities in the information and insurance services industries and has led the firm's investment in 21st Services, a Minneapolis-based company that provides life expectancy information used in the life settlement industry, and also Confie Seguros, a platform company to consolidate insurance brokerages primarily focused on the Hispanic consumer.

About Genstar Capital, LLC

Genstar Capital (http://www.gencap.com) is a leading private equity firm that for 20 years has been actively investing in high quality middle-market companies and building value in those businesses by utilizing the expertise of its operating partners. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating partners and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, industrial technology, software, and business services industries.

Contact: Chris Tofalli

Chris Tofalli Public Relations

914-834-4334


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genstar Capital Appoints Mark Hanson to Managing Director
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. AtriCure to Present at Roth Capital Partners 2007 New York Conference
4. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
5. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Advanced Life Sciences Joins NASDAQ Capital Market
10. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
11. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: